New York State Common Retirement Fund Alnylam Pharmaceuticals, Inc. Transaction History

New York State Common Retirement Fund

  • $75.2 Billion
  • Q2 2025

A detailed history of New York State Common Retirement Fund transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 63,272 shares of ALNY stock, worth $27.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
63,272
Previous 64,272 1.56%
Holding current value
$27.2 Million
Previous $17.4 Million 18.88%
% of portfolio
0.03%
Previous 0.03%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$224.32 - $326.09 $224,320 - $326,090
-1,000 Reduced 1.56%
63,272 $20.6 Million
Q1 2025

May 01, 2025
SELL
$233.07 - $290.7 $1.85 Million - $2.31 Million
-7,956 Reduced 11.02%
64,272 $17.4 Million
Q4 2024

Jan 31, 2025
SELL
$232.27 - $300.43 $929,080 - $1.2 Million
-4,000 Reduced 5.25%
72,228 $17 Million
Q3 2024

Oct 28, 2024
SELL
$233.81 - $287.01 $4.32 Million - $5.3 Million
-18,457 Reduced 19.49%
76,228 $21 Million
Q2 2024

Jul 31, 2024
BUY
$143.31 - $247.0 $131,701 - $226,993
919 Added 0.98%
94,685 $23 Million
Q1 2024

May 07, 2024
SELL
$146.51 - $198.2 $2.66 Million - $3.6 Million
-18,148 Reduced 16.22%
93,766 $14 Million
Q4 2023

Feb 01, 2024
SELL
$151.41 - $196.57 $1.98 Million - $2.57 Million
-13,049 Reduced 10.44%
111,914 $21.4 Million
Q3 2023

Nov 07, 2023
SELL
$170.77 - $211.65 $2.93 Million - $3.63 Million
-17,156 Reduced 12.07%
124,963 $22.1 Million
Q2 2023

Aug 07, 2023
SELL
$185.01 - $212.05 $1.1 Million - $1.27 Million
-5,969 Reduced 4.03%
142,119 $27 Million
Q1 2023

May 18, 2023
BUY
$182.66 - $235.53 $73,064 - $94,212
400 Added 0.27%
148,088 $29.7 Million
Q1 2023

May 02, 2023
SELL
$182.66 - $235.53 $1.28 Million - $1.65 Million
-7,010 Reduced 4.53%
147,688 $29.6 Million
Q4 2022

Jan 30, 2023
BUY
$185.53 - $241.31 $1.24 Million - $1.61 Million
6,680 Added 4.51%
154,698 $36.8 Million
Q3 2022

Nov 08, 2022
SELL
$138.54 - $232.0 $707,385 - $1.18 Million
-5,106 Reduced 3.33%
148,018 $29.6 Million
Q2 2022

Aug 04, 2022
SELL
$120.42 - $169.29 $4.04 Million - $5.68 Million
-33,576 Reduced 17.98%
153,124 $22.3 Million
Q1 2022

May 05, 2022
SELL
$127.18 - $173.91 $119,676 - $163,649
-941 Reduced 0.5%
186,700 $30.5 Million
Q4 2021

Feb 02, 2022
BUY
$159.56 - $209.29 $1.07 Million - $1.41 Million
6,717 Added 3.71%
187,641 $31.8 Million
Q3 2021

Nov 02, 2021
SELL
$169.75 - $207.73 $542,521 - $663,905
-3,196 Reduced 1.74%
180,924 $34.2 Million
Q2 2021

Aug 02, 2021
SELL
$128.63 - $176.89 $42,962 - $59,081
-334 Reduced 0.18%
184,120 $31.2 Million
Q1 2021

May 11, 2021
SELL
$126.83 - $175.69 $1.79 Million - $2.48 Million
-14,100 Reduced 7.1%
184,454 $26 Million
Q4 2020

Feb 08, 2021
SELL
$122.97 - $147.0 $2.61 Million - $3.12 Million
-21,200 Reduced 9.65%
198,554 $25.8 Million
Q3 2020

Nov 05, 2020
SELL
$121.19 - $165.49 $2.76 Million - $3.77 Million
-22,795 Reduced 9.4%
219,754 $32 Million
Q2 2020

Aug 07, 2020
BUY
$104.21 - $156.44 $241,767 - $362,940
2,320 Added 0.97%
242,549 $35.9 Million
Q1 2020

May 06, 2020
SELL
$93.12 - $133.99 $1.22 Million - $1.75 Million
-13,091 Reduced 5.17%
240,229 $26.1 Million
Q4 2019

Feb 05, 2020
SELL
$74.51 - $124.23 $559,793 - $933,339
-7,513 Reduced 2.88%
253,320 $29.2 Million
Q3 2019

Nov 07, 2019
BUY
$70.9 - $87.82 $1.35 Million - $1.67 Million
19,071 Added 7.89%
260,833 $21 Million
Q2 2019

Aug 09, 2019
BUY
$65.86 - $92.79 $1.21 Million - $1.71 Million
18,399 Added 8.24%
241,762 $17.5 Million
Q1 2019

May 08, 2019
BUY
$72.76 - $93.45 $815,057 - $1.05 Million
11,202 Added 5.28%
223,363 $20.9 Million
Q4 2018

Feb 08, 2019
BUY
$62.67 - $88.33 $335,472 - $472,830
5,353 Added 2.59%
212,161 $15.5 Million
Q3 2018

Nov 07, 2018
BUY
$87.52 - $122.67 $334,939 - $469,458
3,827 Added 1.89%
206,808 $18.1 Million
Q2 2018

Aug 10, 2018
SELL
$88.31 - $107.8 $1.1 Million - $1.35 Million
-12,500 Reduced 5.8%
202,981 $20 Million
Q1 2018

May 10, 2018
SELL
$115.92 - $148.54 $185,472 - $237,664
-1,600 Reduced 0.74%
215,481 $25.7 Million
Q4 2017

Feb 13, 2018
BUY
$114.49 - $139.98 $67,892 - $83,008
593 Added 0.27%
217,081 $27.6 Million
Q3 2017

Nov 06, 2017
BUY
$72.53 - $118.27 $979,155 - $1.6 Million
13,500 Added 6.65%
216,488 $25.4 Million
Q2 2017

Aug 11, 2017
BUY
N/A
202,988
202,988 $16.2 Million

Others Institutions Holding ALNY

# of Institutions
742
Shares Held
115M
Call Options Held
584K
Put Options Held
672K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $52.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email